Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results
An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.
Drugs
Health
Pharma
Drugs
Health
Pharma
Scotland’s medical university team cures Parkinson’s patient’s tremors
Scotland's researchers and doctors have performed a non-invasive operation on a patient with Parkinson’s disease using the country’s first ultrasound thalamotomy that allowed.
Climate
Health
Pharma
Opinion: Pesticide exposure and its link to Parkinson’s disease
Understanding the genetic and environmental factors contributing to the development of Parkinson’s is crucial for improving prevention and treatment strategies.
Drugs
Health
Pharma
Simple skin biopsy test can detect Parkinson’s disease: Harvard study
HQ Team March 21, 2024: An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark.
Drugs
Health
Pharma
AbbVie to acquire Cerevel for $8.7b to bolster neurological treatments
HQ Team December 7, 2023: AbbVie Inc., will buy Cerevel Therapeutics, developing drugs for neuroscience diseases, for $8.7 billion in a bid to.
Drugs
Health
Pharma
Swedish researchers identify new biomarker to detect Parkinson’s disease
HQ Team September 26, 2023: Researchers at Sweden’s Lund University have identified a new biomarker to detect Parkinson’s disease before a person develops.
Drugs
Medical
Pharma
Simple blood test can diagnose Parkinson’s Disease at an early stage
HQ Team September 2, 2023: A simple blood test can diagnose Parkinson’s disease which afflicts more than 10 million people globally, according to.
Drugs
Health
Medical
Prebiotic bar intake shows promise in easing Parkinson’s
HQ Team July 22, 2023:A study suggests that constipation, a common early symptom in Parkinson’s diagnosis, may result from an abnormal microbiome in.
Drugs
Health
Pharma
Fatigue in long Covid patients same as in stage IV lung cancer
HQ Team June 14, 2023: Long-Covid-19 patients have fatigue similar to cancer-related anemia, severe kidney disease, and Parkinson’s disease, a study by the .
Drugs
Health
Medical
Parkinson’s drug Ropinirole shows promise as potential treatment for ALS, study finds
HQ Team June 7, 2023: Ropinirole, a drug already approved for the treatment of Parkinson’s disease, has shown potential as a treatment for.